Publications by authors named "Isabelle Lascombe"

Claim this Profile
C
Concomitant decrease of E- and A-FABP expression predicts worse survival in urothelial bladder cancer patients.
Inès Saizonou, Isabelle Lascombe, Franck Monnien, Isabelle Bedgedjian, François Kleinclauss

Sci Rep· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GW501516-Mediated Targeting of Tetraspanin 15 Regulates ADAM10-Dependent N-Cadherin Cleavage in Invasive Bladder Cancer Cells.
Alexandre Barbaud, Isabelle Lascombe, Adeline Péchery, Sergen Arslan, François Kleinclauss

Cells· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular and nanoscale evaluation of N-cadherin expression in invasive bladder cancer cells under control conditions or GW501516 exposure.
Céline Elie-Caille, Isabelle Lascombe, Adeline Péchery, Hugues Bittard, Sylvie Fauconnet

Mol Cell Biochem· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Down-regulation of A-FABP predicts non-muscle invasive bladder cancer progression: investigation with a long term clinical follow-up.
Christel Mathis, Isabelle Lascombe, Franck Monnien, Hugues Bittard, François Kleinclauss

BMC Cancer· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell death and restoration of TRAIL-sensitivity by ciglitazone in resistant cervical cancer cells.
Marie-Laure Plissonnier, Sylvie Fauconnet, Hugues Bittard, Christiane Mougin, Jean Rommelaere, Isabelle Lascombe

Oncotarget· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apoptotic effect of the selective PPARβ/δ agonist GW501516 in invasive bladder cancer cells.
Adeline Péchery, Sylvie Fauconnet, Hugues Bittard, Isabelle Lascombe

Tumour Biol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The PPARβ agonist L-165041 promotes VEGF mRNA stabilization in HPV18-harboring HeLa cells through a receptor-independent mechanism.
Emmanuelle Roche, Isabelle Lascombe, Hugues Bittard, Christiane Mougin, Sylvie Fauconnet

Cell Signal· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The antidiabetic drug ciglitazone induces high grade bladder cancer cells apoptosis through the up-regulation of TRAIL.
Marie-Laure Plissonnier, Sylvie Fauconnet, Hugues Bittard, Isabelle Lascombe

PLoS One· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insights on distinct pathways of thiazolidinediones (PPARgamma ligand)-promoted apoptosis in TRAIL-sensitive or -resistant malignant urothelial cells.
Marie Laure Plissonnier, Sylvie Fauconnet, Hugues Bittard, Isabelle Lascombe

Int J Cancer· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phospho-Akt pathway activation and inhibition depends on N-cadherin or phospho-EGFR expression in invasive human bladder cancer cell lines.
Hervé Wallerand, Ying Cai, Zev A Wainberg, Isla Garraway, Isabelle Lascombe

Urol Oncol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression analysis of VEGF-A and VEGF-B: relationship with clinicopathological parameters in bladder cancer.
Sylvie Fauconnet, Stephane Bernardini, Isabelle Lascombe, Guillaume Boiteux, Anne Clairotte

Oncol Rep· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A-FABP, a candidate progression marker of human transitional cell carcinoma of the bladder, is differentially regulated by PPAR in urothelial cancer cells.
Guillaume Boiteux, Isabelle Lascombe, Emmanuelle Roche, Marie-Laure Plissonnier, Anne Clairotte

Int J Cancer· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The human papillomavirus type 18 E6 oncoprotein induces Vascular Endothelial Growth Factor 121 (VEGF121) transcription from the promoter through a p53-independent mechanism.
Nicolas Clere, Laurent Bermont, Sylvie Fauconnet, Isabelle Lascombe, Maëlle Saunier

Exp Cell Res· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N-cadherin as a novel prognostic marker of progression in superficial urothelial tumors.
Isabelle Lascombe, Anne Clairotte, Sylvie Fauconnet, Stéphane Bernardini, Hervé Wallerand

Clin Cancer Res· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of E-cadherin and alpha-, beta-, gamma-catenins in patients with bladder cancer: identification of gamma-catenin as a new prognostic marker of neoplastic progression in T1 superficial urothelial tumors.
Anne Clairotte, Isabelle Lascombe, Sylvie Fauconnet, Frédéric Mauny, Sophie Félix

Am J Clin Pathol· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential regulation of vascular endothelial growth factor expression by peroxisome proliferator-activated receptors in bladder cancer cells.
Sylvie Fauconnet, Isabelle Lascombe, Eric Chabannes, Gérard-Louis Adessi, Béatrice Desvergne

J Biol Chem· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis